Condition category
Mental and Behavioural Disorders
Date applied
05/03/2007
Date assigned
26/09/2007
Last edited
26/09/2007
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

http://sa.online-therapy.ch

Contact information

Type

Scientific

Primary contact

Prof Franz Caspar

ORCID ID

Contact details

40 Blv. du Pont d'Arve
Geneva
1211
Switzerland
franz.caspar@pse.unige.ch

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

100011-112345

Study information

Scientific title

Acronym

OSP Trial (Online Social Phobia Trial)

Study hypothesis

To determine whether a new, web-based version of cognitive therapy is an effective treatment for social phobia.

Ethics approval

Approved by the Swiss National Science Foundation on 1 April 2006.

Study design

Randomised controlled trial.

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Not specified

Trial type

Not Specified

Patient information sheet

Condition

Social phobia

Intervention

1. Web-based cognitive-behavioral treatment (10 weeks)
2. 10 week wait-list control condition
Patients initially allocated to wait will subsequently receive the web-based cognitive-behavioral treatment.

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

The following will be performed at pre-assessment (baseline), post-assessment (at 10 weeks) and follow-up (at 6 months):
1. Social Phobia Scale
2. Social Interaction Scale
3. Liebowitz Social Anxiety Scale

Secondary outcome measures

The following will be performed at pre-assessment (baseline), post-assessment (at 10 weeks) and follow-up (at 6 months):
1. Symptom Check List (SCL-90-R)
2. Beck Depression Inventory (BDI)
3. State-Trait Anxiety Inventory (STAI)
4. Inventory of Interpersonal Problems (IIP)
5. Goal Attainment Scaling (GAS)

Overall trial start date

20/03/2007

Overall trial end date

30/06/2008

Reason abandoned

Eligibility

Participant inclusion criteria

1. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) (American Psychiatric Association, 1994) criteria for social phobia. Assessed with the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders IV (SCID IV)
2. Patients are included if the cut off score is reached on the Social Phobia Scale and Social Interaction Scale
3. Age 18 to 35
4. Willing to accept random allocation

Participant type

Patient

Age group

Adult

Gender

Both

Target number of participants

50

Participant exclusion criteria

1. Current or past psychosis
2. Borderline personality disorder (other personality disorders are not a reason for exclusion)

Recruitment start date

20/03/2007

Recruitment end date

30/06/2008

Locations

Countries of recruitment

Switzerland

Trial participating centre

40 Blv. du Pont d'Arve
Geneva
1211
Switzerland

Sponsor information

Organisation

The Swiss National Science Foundation (Switzerland)

Sponsor details

Division I: Humanities and Social Sciences
Wildhainweg 3
Postfach 8232
Berne
3001
Switzerland
div1@snf.ch

Sponsor type

Government

Website

http://www.snf.ch

Funders

Funder type

Government

Funder name

The Swiss National Science Foundation (Grant ref: 100011-112345)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes